Lymph node assessment and lymphadenectomy in bladder cancer-Reference-Cited by-同舟云学术

Lymph node assessment and lymphadenectomy in bladder cancer

Published:2009-03-15 Issue:4 Volume:99 Page:225-231
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Sharir Sharon,Fleshner Neil E.

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference71 articles.

1. Canadian Cancer Statistics 2008. Toronto: Canadian Cancer Society/National Cancer Institute of Canada. 2008 [cited December 13, 2008]. Available from: http://www.cancer.ca/Canada-wide/About%20cancer/Cancer%20statistics/Canadian%20Cancer%20Statistics.aspx?sc_lang=en.

2. Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States;Schned;Scand J Urol Nephrol,2008

3. A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years;Larsson;Scand J Urol Nephrol,2003

4. Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period;Holmäng;Scand J Urol Nephrol,2000

5. Toward quality measures in bladder cancer surgery: A population-based assessment of radical cystectomy in Ontario;Kurtz;J Urol,2008

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Significance of Lymph Node Density in Pathological Node Positive Urothelial Carcinoma of the Bladder -Upfront Surgery and Post Neoadjuvant Chemotherapy Cohorts;Clinical Genitourinary Cancer;2023-12

2. The Usefulness of Lymphadenectomy in Bladder Cancer—Current Status;Medicina;2021-04-25

3. Sentinel lymph node imaging in urologic oncology;Translational Andrology and Urology;2018-10

4. Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer;Nature Reviews Urology;2018-08-13

5. Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma;Investigative and Clinical Urology;2017